ST上昇型急性心筋梗塞の診療に関するガイドライン（2013年改訂版）
Guidelines for the management of patients with ST-elevation acute myocardial infarction
（JCS 2013）
文献
601. Chia BL, Tan HC, Yip JW, et al. Electrocardiographic patterns in posterior chest leads (V7, V8, V9) in normal subjects. Am J Cardiol 2000; 85: 911-
912, A910.
602. Buller CE, Fu Y, Mahaffey KW, et al. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial
infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation 2008; 118: 1335-1346.
603. de Lemos JA, Braunwald E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol 2001; 38: 1283-1294.
604. Feldman LJ, Coste P, Furber A, et al. Incomplete resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction after stenting
for acute myocardial infarction. Circulation 2003; 107: 2684-2689.
605. Moon JC, De Arenaza DP, Elkington AG, et al. The pathologic basis of Q-wave and non-Q-wave myocardial infarction: a cardiovascular magnetic
resonance study. J Am Coll Cardiol 2004; 44: 554-560.
606. Maeda S, Imai T, Kuboki K, et al. Pathologic implications of restored positive T waves and persistent negative T waves after Q wave myocardial
infarction. J Am Coll Cardiol 1996; 28: 1514-1518.
607. Isobe S, Okada M, Ando A, et al. Clinical significance of changes in electrocardiographic R-wave voltage on chest leads in patients with acute anterior
myocardial infarction. J Electrocardiol 2002; 35: 173-180.
608. Selvester RH, Wagner GS, Hindman NB. The Selvester QRS scoring system for estimating myocardial infarct size. The development and application
of the system. Arch Intern Med 1985; 145: 1877-1881.
609. Buja LM, Willerson JT. Infarct size―can it be measured or modified in humans? Prog Cardiovasc Dis 1987; 29: 271-289.
610. Hackel DB, Reimer KA, Ideker RE, et al. Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation 1984; 70:
824-835.
611. Savonitto S, Granger CB, Ardissino D, et al; GUSTO-IIb Investigators. The prognostic value of creatine kinase elevations extends across the whole
spectrum of acute coronary syndromes. J Am Coll Cardiol 2002; 39: 22-29.
612. Chia S, Senatore F, Raffel OC, et al. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after
primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2008; 1: 415-423.
613. Licka M, Zimmermann R, Zehelein J, et al. Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size.
Heart 2002; 87: 520-524.
614. Steen H, Giannitsis E, Futterer S, et al. Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac
function. J Am Coll Cardiol 2006; 48: 2192-2194.
615. Bonaca M, Scirica B, Sabatine M, et al. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay
for cardiac troponin I. J Am Coll Cardiol 2010; 55: 2118-2124.
616. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American
Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc
Echocardiogr 1989; 2: 358-367.
617. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A
statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.
Circulation 2002; 105: 539-542.
618. Oh JK, Gibbons RJ, Christian TF, et al. Correlation of regional wall motion abnormalities detected by two-dimensional echocardiography with perfusion
defect determined by technetium 99m sestamibi imaging in patients treated with reperfusion therapy during acute myocardial infarction. Am Heart J
1996; 131: 32-37.
619. Shen WK, Khandheria BK, Edwards WD, et al. Value and limitations of two-dimensional echocardiography in predicting myocardial infarct size. Am J
Cardiol 1991; 68: 1143-1149.
620. Gibson RS, Bishop HL, Stamm RB, et al. Value of early two dimensional echocardiography in patients with acute myocardial infarction. Am J Cardiol
1982; 49: 1110-1119.
621. Horowitz RS, Morganroth J, Parrotto C, et al. Immediate diagnosis of acute myocardial infarction by two-dimensional echocardiography. Circulation
1982; 65: 323-329.
622. Balcells E, Powers ER, Lepper W, et al. Detection of myocardial viability by contrast echocardiography in acute infarction predicts recovery of resting
function and contractile reserve. J Am Coll Cardiol 2003; 41: 827-833.
623. 循環器病の診断と治療に関するガイドライン．循環器超音波検査の適応と判読ガイドライン（2010年改訂版）．http://www.j-
circ.or.jp/guideline/pdf/JCS2010yoshida.h.pdf（2012年12月閲覧）
624. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of
the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995
Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003; 42: 1318-1333.
625. Nakata T, Noto T, Uno K, et al. Quantification of area and percentage of infarcted myocardium by single photon emission computed tomography with
thallium-201: a comparison with serial serum CK-MB measurements. Ann Nucl Med 1989; 3: 1-8.
626. Tamaki S, Nakajima H, Murakami T, et al. Estimation of infarct size by myocardial emission computed tomography with thallium-201 and its relation
to creatine kinase-MB release after myocardial infarction in man. Circulation 1982; 66: 994-1001.
627. Verani MS, Jeroudi MO, Mahmarian JJ, et al. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion
using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol 1988; 12: 1573-1581.
628. Christian TF, Clements IP, Gibbons RJ. Noninvasive identification of myocardium at risk in patients with acute myocardial infarction and nondiagnostic
electrocardiograms with technetium-99m-Sestamibi. Circulation 1991; 83: 1615-1620.
629. Gibbons RJ, Verani MS, Behrenbeck T, et al. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the
assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 1989; 80: 1277-1286.
630. Miller TD, Christian TF, Hopfenspirger MR, et al. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi
imaging predicts subsequent mortality. Circulation 1995; 92: 334-341.
631. Kapur A, Latus KA, Davies G, et al. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study.
Eur J Nucl Med Mol Imaging 2002; 29: 1608-1616.
632. Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease:
a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll
Cardiol 1995; 26: 639-647.
633. Kauffman GJ, Boyne TS, Watson DD, et al. Comparison of res thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of
myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol 1996; 27: 1592-1597.
634. Maurea S, Cuocolo A, Soricelli A, et al. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in
chronic coronary artery disease. J Nucl Med 1995; 36: 1945-1952.
635. Levine MG, McGill CC, Ahlberg AW, et al. Functional assessment with electrocardiographic gated single-photon emission computed tomography
improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization.
Am J Cardiol 1999; 83: 1-5.
636. Hashimoto A, Nakata T, Tsuchihashi K, et al. Postischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary
angioplasty in acute myocardial infarction. Am J Cardiol 1996; 77: 25-30.
637. Nakata T, Kobayashi T, Tamaki N, et al. Prognostic value of impaired myocardial fatty acid uptake in patients with acute myocardial infarction. Nucl
Med Commun 2000; 21: 897-906.
638. Nishimura T, Nishimura S, Kajiya T, et al. Prediction of functional recovery and prognosis in patients with acute myocardial infarction by 123I-BMIPP
and 201Tl myocardial single photon emission computed tomography: a multicenter trial. Ann Nucl Med 1998; 12: 237-248.
639. Tamaki N, Tadamura E, Kudoh T, et al. Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial
infarction. Eur J Nucl Med 1996; 23: 272-279.
640. Corbett JR, Lewis SE, Wolfe CL, et al. Measurement of myocardial infarct size by technetium pyrophosphate single-photon tomography. Am J Cardiol
1984; 54: 1231-1236.
641. Holman BL, Goldhaber SZ, Kirsch CM, et al. Measurement of infarct size using single photon emission computed tomography and technetium-99m
pyrophosphate: a description of the method and comparison with patient prognosis. Am J Cardiol 1982; 50: 503-511.
642. 循環器病の診断と治療に関するガイドライン．心臓核医学検査ガイドライン（2010年改訂版）．http://www.j-circ.or.jp/guideline/pdf/JCS2010tamaki.h.pdf（2012
年12月閲覧）
643. Moon JC, Lorenz CH, Francis JM, et al. Breath-hold FLASH and FISP cardiovascular MR imaging: left ventricular volume differences and
reproducibility. Radiology 2002; 223: 789-797.
644. Barkhausen J, Ruehm SG, Goyen M, et al. MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle
shot cine MR imaging: feasibility study. Radiology 2001; 219: 264-269.
645. Grothues F, Smith GC, Moon JC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with twodimensional
echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002; 90: 29-34.
646. Ichikawa Y, Sakuma H, Kitagawa K, et al. Evaluation of left ventricular volumes and ejection fraction using fast steady-state cine MR imaging:
comparison with left ventricular angiography. J Cardiovasc Magn Reson 2003; 5: 333-342.
647. Tsao J, Boesiger P, Pruessmann KP. k-t BLAST and k-t SENSE: dynamic MRI with high frame rate exploiting spatiotemporal correlations. Magn
Reson Med 2003; 50: 1031-1042.
648. Budoff MJ, Cohen MC, Garcia MJ, et al. ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic
resonance: a report of the American College of Cardiology Foundation/American Heart Association/ American College of Physicians Task Force on
Clinical Competence and Training. J Am Coll Cardiol 2005; 46: 383-402.
649. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion
imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003; 361: 374-379.
650. Ingkanisorn WP, Rhoads KL, Aletras AH, et al. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical
measures of myocardial infarction. J Am Coll Cardiol 2004; 43: 2253-2259.
651. Thiele H, Kappl MJ, Conradi S, et al. Reproducibility of chronic and acute infarct size measurement by delayed enhancementmagnetic
resonance imaging. J Am Coll Cardiol 2006; 47: 1641-1645.
652. Kim RJ, Albert TS, Wible JH, et al. Performance of delayedenhancement magnetic resonance imaging with gadoversetamide contrast for the detection
and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation 2008; 117: 629-637.
653. Rochitte CE, Lima JA, Bluemke DA, et al. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction.
Circulation 1998; 98: 1006-1014.
654. Taylor AJ, Al-Saadi N, Abdel-Aty H, et al. Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance
imaging. Circulation 2004; 109: 2080-2085.
655. Baks T, van Geuns RJ, Biagini E, et al. Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular
wall characteristics. J Am Coll Cardiol 2006; 47: 40-44.
656. Kumar A, Abdel-Aty H, Kriedemann I, et al. Contrast-enhanced cardiovascular magnetic resonance imaging of right ventricular infarction. J Am Coll
Cardiol 2006; 48: 1969-1976.
657. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.
Circulation 1999; 100: 1992-2002.
658. Fieno DS, Kim RJ, Chen EL, et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and
irreversible injury throughout infarct healing. J Am Coll Cardiol 2000; 36: 1985-1991.
659. Gerber BL, Rochitte CE, Bluemke DA, et al. Relation between Gd-DTPA contrast enhancement and regional inotropic response in the periphery
and center of myocardial infarction. Circulation 2001; 104: 998-1004.
660. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with
positron emission tomography. Circulation 2002; 105: 162-167.
661. Wu E, Judd RM, Vargas JD, et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction.
Lancet 2001; 357: 21-28.
662. Choi KM, Kim RJ, Gubernikoff G, et al. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function.
Circulation 2001; 104: 1101-1107.
663. Hillenbrand HB, Kim RJ, Parker MA, et al. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation
2000; 102: 1678-1683.
664. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med
2000; 343: 1445-1453.
665. Selvanayagam JB, Kardos A, Francis JM, et al. Value of delayedenhancement cardiovascular magnetic resonance imaging in predicting myocardial
viability after surgical revascularization. Circulation 2004; 110: 1535-1541.
666. Ichikawa Y, Sakuma H, Suzawa N, et al. Late gadoliniumenhanced magnetic resonance imaging in acute and chronic myocardial infarction. Improved
prediction of regional myocardial contraction in the chronic state by measuring thickness of nonenhanced myocardium. J Am Coll Cardiol 2005; 45:
901-909.
667. Ramani K, Judd RM, Holly TA, et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary
artery disease and left ventricular dysfunction. Circulation 1998; 98: 2687-2694.
668. Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic
significance as assessed by magnetic resonance imaging. Eur Heart J 2005; 26: 549-557.
669. O'Regan DP, Ariff B, Neuwirth C, et al. Assessment of severe reperfusion injury with T2* cardiac MRI in patients with acute myocardial infarction. Heart
2010; 96: 1885-1891.
670. Mather AN, Fairbairn TA, Ball SG, et al. Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular
remodelling and markers of late arrhythmic risk. Heart 2011; 97: 453-459.
671. Rogers WJ, Kramer CM, Geskin G, et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction.
Circulation 1999; 99: 744-750.
672. Choi CJ, Haji-Momenian S, Dimaria JM, et al. Infarct involution and improved function during healing of acute myocardial infarction: the role of
microvascular obstruction. J Cardiovasc Magn Reson 2004; 6: 917-925.
673. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute
myocardial infarction. Circulation 1998; 97: 765-772.
674. Sorajja P, Gersh BJ, Cox DA, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary
percutaneous coronary intervention for acute myocardial infarction. Eur Heart J 2007; 28: 1709-1716.
675. 循環器病の診断と治療に関するガイドライン 安定冠動脈疾患における待機的PCIのガイドライン（2011年改訂版）．http://www.j-
circ.or.jp/guideline/pdf/JCS2011_fujiwara_h.pdf（2012年12月閲覧）
676. 循環器病の診断と治療に関するガイドライン 虚血性心疾患に対するバイパスグラフトと手術術式の選択ガイドライン（2011年改訂版）．http://www.j-
circ.or.jp/guideline/pdf/JCS2011_ochi_h.pdf（2012年12月閲覧）
677. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery
disease. N Engl J Med 2009; 360: 961-972.
678. Mohr F, Redwood S, Venn G, et al. TCT-43 Final five-year follow-up of the SYNTAX trial: optimal revascularization strategy in patients with three-vessel
disease. J Am Coll Cardiol 2012; 60: B13.
679. Vlaar PJ, Mahmoud KD, Holmes DR, et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel
disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network metaanalysis. J Am Coll Cardiol 2011; 58:
692-703.
680. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008; 358:
331-341.
681. Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or
three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011; 32: 2125-2134.
682. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by
the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344: 563-570.
683. Velazquez EJ, Lee KL, Deja MA, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011; 364: 1607-
1616.
684. Lytle BW, Blackstone EH, Sabik JF, et al. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac
Surg 2004; 78: 2005-2012; discussion 2012-2004.
685. Puskas JD, Thourani VH, Kilgo P, et al. Off-pump coronary artery bypass disproportionately benefits high-risk patients. Ann Thorac Surg 2009; 88:
1142-1147.
686. Ebrahimi R, Dyke C, Mehran R, et al. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes
undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol 2009;
53: 1965-1972.
687. Chaitman BR, McMahon RP, Terrin M, et al. Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction
(TIMI) II Trial. Am J Cardiol 1993; 71: 131-138.
688. Rouleau JL, Talajic M, Sussex B, et al. Myocardial infarction patients in the 1990s--their risk factors, stratification and survival in Canada: the
Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol 1996; 27: 1119-1127.
689. Theroux P, Waters DD, Halphen C, et al. Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med 1979; 301: 341-345.
690. DeBusk RF, Kraemer HC, Nash E, et al. Stepwise risk stratification soon after acute myocardial infarction. Am J Cardiol 1983; 52: 1161-1166.
691. Krone RJ, Gillespie JA, Weld FM, et al. Low-level exercise testing after myocardial infarction: usefulness in enhancing clinical risk stratification.
Circulation 1985; 71: 80-89.
692. Newby LK, Califf RM, Guerci A, et al. Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global
Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. J Am Coll Cardiol 1996; 27: 625-632.
693. Froelicher VF, Perdue S, Pewen W, et al. Application of metaanalysis using an electronic spread sheet to exercise testing in patients after
myocardial infarction. Am J Med 1987; 83: 1045-1054.
694. Villella A, Maggioni AP, Villella M, et al. Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic
agents: the GISSI-2 data-base. Gruppo Italiano per lo Studio della Sopravvivenza Nell'Infarto. Lancet 1995; 346: 523-529.
695. Shaw LJ, Peterson ED, Kesler K, et al. A metaanalysis of predischarge risk stratification after acute myocardial infarction with stress
electrocardiographic, myocardial perfusion, and ventricular function imaging. Am J Cardiol 1996; 78: 1327-1337.
696. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary
article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to
Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr 2003; 16: 1091-1110.
697. Anderson JL, Karagounis LA, Becker LC, et al. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial
infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study. Circulation 1993; 87: 1829-1839.
698. Ahnve S, Gilpin E, Henning H, et al. Limitations and advantages of the ejection fraction for defining high risk after acute myocardial infarction. Am J
Cardiol 1986; 58: 872-878.
699. Launbjerg J, Berning J, Fruergaard P, et al. Risk stratification after acute myocardial infarction by means of echocardiographic wall motion scoring
and Killip classification. Cardiology 1992; 80: 375-381.
700. Pozzoli M, Capomolla S, Sanarico M, et al. Doppler evaluations of left ventricular diastolic filling and pulmonary wedge pressure provide similar
prognostic information in patients with systolic dysfunction after myocardial infarction. Am Heart J 1995; 129: 716-725.
912, A910.
602. Buller CE, Fu Y, Mahaffey KW, et al. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial
infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation 2008; 118: 1335-1346.
603. de Lemos JA, Braunwald E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol 2001; 38: 1283-1294.
604. Feldman LJ, Coste P, Furber A, et al. Incomplete resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction after stenting
for acute myocardial infarction. Circulation 2003; 107: 2684-2689.
605. Moon JC, De Arenaza DP, Elkington AG, et al. The pathologic basis of Q-wave and non-Q-wave myocardial infarction: a cardiovascular magnetic
resonance study. J Am Coll Cardiol 2004; 44: 554-560.
606. Maeda S, Imai T, Kuboki K, et al. Pathologic implications of restored positive T waves and persistent negative T waves after Q wave myocardial
infarction. J Am Coll Cardiol 1996; 28: 1514-1518.
607. Isobe S, Okada M, Ando A, et al. Clinical significance of changes in electrocardiographic R-wave voltage on chest leads in patients with acute anterior
myocardial infarction. J Electrocardiol 2002; 35: 173-180.
608. Selvester RH, Wagner GS, Hindman NB. The Selvester QRS scoring system for estimating myocardial infarct size. The development and application
of the system. Arch Intern Med 1985; 145: 1877-1881.
609. Buja LM, Willerson JT. Infarct size―can it be measured or modified in humans? Prog Cardiovasc Dis 1987; 29: 271-289.
610. Hackel DB, Reimer KA, Ideker RE, et al. Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation 1984; 70:
824-835.
611. Savonitto S, Granger CB, Ardissino D, et al; GUSTO-IIb Investigators. The prognostic value of creatine kinase elevations extends across the whole
spectrum of acute coronary syndromes. J Am Coll Cardiol 2002; 39: 22-29.
612. Chia S, Senatore F, Raffel OC, et al. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after
primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2008; 1: 415-423.
613. Licka M, Zimmermann R, Zehelein J, et al. Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size.
Heart 2002; 87: 520-524.
614. Steen H, Giannitsis E, Futterer S, et al. Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac
function. J Am Coll Cardiol 2006; 48: 2192-2194.
615. Bonaca M, Scirica B, Sabatine M, et al. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay
for cardiac troponin I. J Am Coll Cardiol 2010; 55: 2118-2124.
616. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American
Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc
Echocardiogr 1989; 2: 358-367.
617. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A
statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.
Circulation 2002; 105: 539-542.
618. Oh JK, Gibbons RJ, Christian TF, et al. Correlation of regional wall motion abnormalities detected by two-dimensional echocardiography with perfusion
defect determined by technetium 99m sestamibi imaging in patients treated with reperfusion therapy during acute myocardial infarction. Am Heart J
1996; 131: 32-37.
619. Shen WK, Khandheria BK, Edwards WD, et al. Value and limitations of two-dimensional echocardiography in predicting myocardial infarct size. Am J
Cardiol 1991; 68: 1143-1149.
620. Gibson RS, Bishop HL, Stamm RB, et al. Value of early two dimensional echocardiography in patients with acute myocardial infarction. Am J Cardiol
1982; 49: 1110-1119.
621. Horowitz RS, Morganroth J, Parrotto C, et al. Immediate diagnosis of acute myocardial infarction by two-dimensional echocardiography. Circulation
1982; 65: 323-329.
622. Balcells E, Powers ER, Lepper W, et al. Detection of myocardial viability by contrast echocardiography in acute infarction predicts recovery of resting
function and contractile reserve. J Am Coll Cardiol 2003; 41: 827-833.
623. 循環器病の診断と治療に関するガイドライン．循環器超音波検査の適応と判読ガイドライン（2010年改訂版）．http://www.j-
circ.or.jp/guideline/pdf/JCS2010yoshida.h.pdf（2012年12月閲覧）
624. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of
the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995
Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003; 42: 1318-1333.
625. Nakata T, Noto T, Uno K, et al. Quantification of area and percentage of infarcted myocardium by single photon emission computed tomography with
thallium-201: a comparison with serial serum CK-MB measurements. Ann Nucl Med 1989; 3: 1-8.
626. Tamaki S, Nakajima H, Murakami T, et al. Estimation of infarct size by myocardial emission computed tomography with thallium-201 and its relation
to creatine kinase-MB release after myocardial infarction in man. Circulation 1982; 66: 994-1001.
627. Verani MS, Jeroudi MO, Mahmarian JJ, et al. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion
using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol 1988; 12: 1573-1581.
628. Christian TF, Clements IP, Gibbons RJ. Noninvasive identification of myocardium at risk in patients with acute myocardial infarction and nondiagnostic
electrocardiograms with technetium-99m-Sestamibi. Circulation 1991; 83: 1615-1620.
629. Gibbons RJ, Verani MS, Behrenbeck T, et al. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the
assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 1989; 80: 1277-1286.
630. Miller TD, Christian TF, Hopfenspirger MR, et al. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi
imaging predicts subsequent mortality. Circulation 1995; 92: 334-341.
631. Kapur A, Latus KA, Davies G, et al. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study.
Eur J Nucl Med Mol Imaging 2002; 29: 1608-1616.
632. Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease:
a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll
Cardiol 1995; 26: 639-647.
633. Kauffman GJ, Boyne TS, Watson DD, et al. Comparison of res thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of
myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol 1996; 27: 1592-1597.
634. Maurea S, Cuocolo A, Soricelli A, et al. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in
chronic coronary artery disease. J Nucl Med 1995; 36: 1945-1952.
635. Levine MG, McGill CC, Ahlberg AW, et al. Functional assessment with electrocardiographic gated single-photon emission computed tomography
improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization.
Am J Cardiol 1999; 83: 1-5.
636. Hashimoto A, Nakata T, Tsuchihashi K, et al. Postischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary
angioplasty in acute myocardial infarction. Am J Cardiol 1996; 77: 25-30.
637. Nakata T, Kobayashi T, Tamaki N, et al. Prognostic value of impaired myocardial fatty acid uptake in patients with acute myocardial infarction. Nucl
Med Commun 2000; 21: 897-906.
638. Nishimura T, Nishimura S, Kajiya T, et al. Prediction of functional recovery and prognosis in patients with acute myocardial infarction by 123I-BMIPP
and 201Tl myocardial single photon emission computed tomography: a multicenter trial. Ann Nucl Med 1998; 12: 237-248.
639. Tamaki N, Tadamura E, Kudoh T, et al. Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial
infarction. Eur J Nucl Med 1996; 23: 272-279.
640. Corbett JR, Lewis SE, Wolfe CL, et al. Measurement of myocardial infarct size by technetium pyrophosphate single-photon tomography. Am J Cardiol
1984; 54: 1231-1236.
641. Holman BL, Goldhaber SZ, Kirsch CM, et al. Measurement of infarct size using single photon emission computed tomography and technetium-99m
pyrophosphate: a description of the method and comparison with patient prognosis. Am J Cardiol 1982; 50: 503-511.
642. 循環器病の診断と治療に関するガイドライン．心臓核医学検査ガイドライン（2010年改訂版）．http://www.j-circ.or.jp/guideline/pdf/JCS2010tamaki.h.pdf（2012
年12月閲覧）
643. Moon JC, Lorenz CH, Francis JM, et al. Breath-hold FLASH and FISP cardiovascular MR imaging: left ventricular volume differences and
reproducibility. Radiology 2002; 223: 789-797.
644. Barkhausen J, Ruehm SG, Goyen M, et al. MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle
shot cine MR imaging: feasibility study. Radiology 2001; 219: 264-269.
645. Grothues F, Smith GC, Moon JC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with twodimensional
echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002; 90: 29-34.
646. Ichikawa Y, Sakuma H, Kitagawa K, et al. Evaluation of left ventricular volumes and ejection fraction using fast steady-state cine MR imaging:
comparison with left ventricular angiography. J Cardiovasc Magn Reson 2003; 5: 333-342.
647. Tsao J, Boesiger P, Pruessmann KP. k-t BLAST and k-t SENSE: dynamic MRI with high frame rate exploiting spatiotemporal correlations. Magn
Reson Med 2003; 50: 1031-1042.
648. Budoff MJ, Cohen MC, Garcia MJ, et al. ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic
resonance: a report of the American College of Cardiology Foundation/American Heart Association/ American College of Physicians Task Force on
Clinical Competence and Training. J Am Coll Cardiol 2005; 46: 383-402.
649. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion
imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003; 361: 374-379.
650. Ingkanisorn WP, Rhoads KL, Aletras AH, et al. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical
measures of myocardial infarction. J Am Coll Cardiol 2004; 43: 2253-2259.
651. Thiele H, Kappl MJ, Conradi S, et al. Reproducibility of chronic and acute infarct size measurement by delayed enhancementmagnetic
resonance imaging. J Am Coll Cardiol 2006; 47: 1641-1645.
652. Kim RJ, Albert TS, Wible JH, et al. Performance of delayedenhancement magnetic resonance imaging with gadoversetamide contrast for the detection
and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation 2008; 117: 629-637.
653. Rochitte CE, Lima JA, Bluemke DA, et al. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction.
Circulation 1998; 98: 1006-1014.
654. Taylor AJ, Al-Saadi N, Abdel-Aty H, et al. Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance
imaging. Circulation 2004; 109: 2080-2085.
655. Baks T, van Geuns RJ, Biagini E, et al. Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular
wall characteristics. J Am Coll Cardiol 2006; 47: 40-44.
656. Kumar A, Abdel-Aty H, Kriedemann I, et al. Contrast-enhanced cardiovascular magnetic resonance imaging of right ventricular infarction. J Am Coll
Cardiol 2006; 48: 1969-1976.
657. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.
Circulation 1999; 100: 1992-2002.
658. Fieno DS, Kim RJ, Chen EL, et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and
irreversible injury throughout infarct healing. J Am Coll Cardiol 2000; 36: 1985-1991.
659. Gerber BL, Rochitte CE, Bluemke DA, et al. Relation between Gd-DTPA contrast enhancement and regional inotropic response in the periphery
and center of myocardial infarction. Circulation 2001; 104: 998-1004.
660. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with
positron emission tomography. Circulation 2002; 105: 162-167.
661. Wu E, Judd RM, Vargas JD, et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction.
Lancet 2001; 357: 21-28.
662. Choi KM, Kim RJ, Gubernikoff G, et al. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function.
Circulation 2001; 104: 1101-1107.
663. Hillenbrand HB, Kim RJ, Parker MA, et al. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation
2000; 102: 1678-1683.
664. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med
2000; 343: 1445-1453.
665. Selvanayagam JB, Kardos A, Francis JM, et al. Value of delayedenhancement cardiovascular magnetic resonance imaging in predicting myocardial
viability after surgical revascularization. Circulation 2004; 110: 1535-1541.
666. Ichikawa Y, Sakuma H, Suzawa N, et al. Late gadoliniumenhanced magnetic resonance imaging in acute and chronic myocardial infarction. Improved
prediction of regional myocardial contraction in the chronic state by measuring thickness of nonenhanced myocardium. J Am Coll Cardiol 2005; 45:
901-909.
667. Ramani K, Judd RM, Holly TA, et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary
artery disease and left ventricular dysfunction. Circulation 1998; 98: 2687-2694.
668. Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic
significance as assessed by magnetic resonance imaging. Eur Heart J 2005; 26: 549-557.
669. O'Regan DP, Ariff B, Neuwirth C, et al. Assessment of severe reperfusion injury with T2* cardiac MRI in patients with acute myocardial infarction. Heart
2010; 96: 1885-1891.
670. Mather AN, Fairbairn TA, Ball SG, et al. Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular
remodelling and markers of late arrhythmic risk. Heart 2011; 97: 453-459.
671. Rogers WJ, Kramer CM, Geskin G, et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction.
Circulation 1999; 99: 744-750.
672. Choi CJ, Haji-Momenian S, Dimaria JM, et al. Infarct involution and improved function during healing of acute myocardial infarction: the role of
microvascular obstruction. J Cardiovasc Magn Reson 2004; 6: 917-925.
673. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute
myocardial infarction. Circulation 1998; 97: 765-772.
674. Sorajja P, Gersh BJ, Cox DA, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary
percutaneous coronary intervention for acute myocardial infarction. Eur Heart J 2007; 28: 1709-1716.
675. 循環器病の診断と治療に関するガイドライン 安定冠動脈疾患における待機的PCIのガイドライン（2011年改訂版）．http://www.j-
circ.or.jp/guideline/pdf/JCS2011_fujiwara_h.pdf（2012年12月閲覧）
676. 循環器病の診断と治療に関するガイドライン 虚血性心疾患に対するバイパスグラフトと手術術式の選択ガイドライン（2011年改訂版）．http://www.j-
circ.or.jp/guideline/pdf/JCS2011_ochi_h.pdf（2012年12月閲覧）
677. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery
disease. N Engl J Med 2009; 360: 961-972.
678. Mohr F, Redwood S, Venn G, et al. TCT-43 Final five-year follow-up of the SYNTAX trial: optimal revascularization strategy in patients with three-vessel
disease. J Am Coll Cardiol 2012; 60: B13.
679. Vlaar PJ, Mahmoud KD, Holmes DR, et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel
disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network metaanalysis. J Am Coll Cardiol 2011; 58:
692-703.
680. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008; 358:
331-341.
681. Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or
three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011; 32: 2125-2134.
682. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by
the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344: 563-570.
683. Velazquez EJ, Lee KL, Deja MA, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011; 364: 1607-
1616.
684. Lytle BW, Blackstone EH, Sabik JF, et al. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac
Surg 2004; 78: 2005-2012; discussion 2012-2004.
685. Puskas JD, Thourani VH, Kilgo P, et al. Off-pump coronary artery bypass disproportionately benefits high-risk patients. Ann Thorac Surg 2009; 88:
1142-1147.
686. Ebrahimi R, Dyke C, Mehran R, et al. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes
undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol 2009;
53: 1965-1972.
687. Chaitman BR, McMahon RP, Terrin M, et al. Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction
(TIMI) II Trial. Am J Cardiol 1993; 71: 131-138.
688. Rouleau JL, Talajic M, Sussex B, et al. Myocardial infarction patients in the 1990s--their risk factors, stratification and survival in Canada: the
Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol 1996; 27: 1119-1127.
689. Theroux P, Waters DD, Halphen C, et al. Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med 1979; 301: 341-345.
690. DeBusk RF, Kraemer HC, Nash E, et al. Stepwise risk stratification soon after acute myocardial infarction. Am J Cardiol 1983; 52: 1161-1166.
691. Krone RJ, Gillespie JA, Weld FM, et al. Low-level exercise testing after myocardial infarction: usefulness in enhancing clinical risk stratification.
Circulation 1985; 71: 80-89.
692. Newby LK, Califf RM, Guerci A, et al. Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global
Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. J Am Coll Cardiol 1996; 27: 625-632.
693. Froelicher VF, Perdue S, Pewen W, et al. Application of metaanalysis using an electronic spread sheet to exercise testing in patients after
myocardial infarction. Am J Med 1987; 83: 1045-1054.
694. Villella A, Maggioni AP, Villella M, et al. Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic
agents: the GISSI-2 data-base. Gruppo Italiano per lo Studio della Sopravvivenza Nell'Infarto. Lancet 1995; 346: 523-529.
695. Shaw LJ, Peterson ED, Kesler K, et al. A metaanalysis of predischarge risk stratification after acute myocardial infarction with stress
electrocardiographic, myocardial perfusion, and ventricular function imaging. Am J Cardiol 1996; 78: 1327-1337.
696. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary
article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to
Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr 2003; 16: 1091-1110.
697. Anderson JL, Karagounis LA, Becker LC, et al. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial
infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study. Circulation 1993; 87: 1829-1839.
698. Ahnve S, Gilpin E, Henning H, et al. Limitations and advantages of the ejection fraction for defining high risk after acute myocardial infarction. Am J
Cardiol 1986; 58: 872-878.
699. Launbjerg J, Berning J, Fruergaard P, et al. Risk stratification after acute myocardial infarction by means of echocardiographic wall motion scoring
and Killip classification. Cardiology 1992; 80: 375-381.
700. Pozzoli M, Capomolla S, Sanarico M, et al. Doppler evaluations of left ventricular diastolic filling and pulmonary wedge pressure provide similar
prognostic information in patients with systolic dysfunction after myocardial infarction. Am Heart J 1995; 129: 716-725.